Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.
| Image |  |
|---|---|
| Description | scientific article published on 15 May 2017 |
| Author/s |
author: Ming-Han Tsai |
| Publication date | July 1, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |